- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0131696

Elet Pharma Private Limited
About Elet Pharma Private Limited
Data last updated:
Elet Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2021PTC197605. Its GSTIN is 09AAGCE2793K1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Vishal Chandra and Sandeep Haldar.
Its last annual general meeting (AGM) was held on 19 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S.No – 55/1/56/1 57/1 To 4 Elementra Defl B/D – 1/1206 Nearbalaji Education Tathawade, Pune, Maharashtra, India – 411033.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.8 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹7,637 (net margin 0.2%) and EBITDA of ₹14,225 (EBITDA margin 0.5%).
Elet Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0131696).
Company details
Recognitions & Rankings of Elet Pharma
Contact details
Elet Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressS.No – 55/1/56/1 57/1 To 4 Elementra Defl B/D – 1/1206 Nearbalaji Education Tathawade, Pune, Maharashtra, India – 411033
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Elet Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elet Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Elet Pharma Private Limited, buy the company report.
Financials of Elet Pharma Private Limited
FY 2025 filings availableElet Pharma Private Limited reported revenue of ₹30.8 Lakh (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,225 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,637 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elet Pharma Private Limited, buy the company report.
Board of directors of Elet Pharma Private Limited
Elet Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Chandra | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
| Sandeep Haldar | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
| Sanjeev Kumar Haldar | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Elet Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sukhi Life Services (OPC) Private Limited | ₹30.97 Lakh (FY 2025) | 110.0% | Hyderabad, Telangana, India | |||
| Dr. Alexander Lab Private Limited | ₹30.89 Lakh (FY 2024) | 36.0% | Delhi, India | |||
| Urban Elite Medicare Foundation | ₹30.89 Lakh (FY 2025) | 23.0% | Shivaji Enclave, Delhi, India | |||
| Dentisti Healthtech Private Limited | ₹30.87 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Shree Rasamrita Ayurveda Private Limited | ₹30.83 Lakh (FY 2025) | Khetri, Rajasthan, India | ||||
| Elet Pharma Private Limitedthis company | ₹30.8 Lakh (FY 2025) | ₹7,637 | 0.2% | -5.0% | Pune, Maharashtra, India | |
| SNS Trading Private Limited | ₹30.8 Lakh (FY 2024) | 269.0% | New Delhi, Delhi, India | |||
| Alnair Pharmaceutical Private Limited | ₹30.76 Lakh (FY 2025) | 27.0% | Bhosari, Maharashtra, India | |||
| Sunlight Healthcare Private Limited | ₹30.67 Lakh (FY 2025) | -94.0% | New Delhi, Delhi, India | |||
| Hi-Reach Hospitals Private Limited | ₹30.62 Lakh (FY 2025) | -11.0% | Chennai, Tamil Nadu, India | |||
| Senesco Pharma Private Limited | ₹30.59 Lakh (FY 2024) | Pune, Maharashtra, India |
To see the full peer comparison of Elet Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Elet Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elet Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elet Pharma Private Limited has 1 active EPFO establishment as of Mar 28, 2024.
GST
Elet Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCE2793K1Z5 | Uttar Pradesh | Active | 16 Feb 2022 |
To see the full GST registrations and return filing status of Elet Pharma Private Limited, buy the company report.
Recent activity
Elet Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Surjeet Haldar ceased to be Director on 08 Jun 2021.
Frequently asked questions
Elet Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 January 2021 (5+ years old) and is registered under CIN U24290PN2021PTC197605.
Elet Pharma has 3 current directors:
- Vishal Chandra - Director
- Sandeep Haldar - Director
- Sanjeev Kumar Haldar - Director
The latest financial statements of Elet Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 July 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Elet Pharma is 09AAGCE2793K1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Elet Pharma is U24290PN2021PTC197605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elet Pharma was incorporated on 11 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Elet Pharma by revenue are Sukhi Life Services (OPC) Private Limited, Dr. Alexander Lab Private Limited, Urban Elite Medicare Foundation, Dentisti Healthtech Private Limited, Shree Rasamrita Ayurveda Private Limited and 5 more, all in the same principal business activity (human health activities).
Surjeet Haldar ceased to be Director on 08 Jun 2021. Sandeep Haldar was appointed as Director on 11 Jan 2021. Sanjeev Kumar Haldar was appointed as Director on 11 Jan 2021. Elet Pharma has 4 board changes on record in total.
Yes, Elet Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0131696).
The registered office of Elet Pharma is at S.No – 551561 571 To 4 Elementra Defl BD – 11206 Nearbalaji Education Tathawade, Pune, Maharashtra, India – 411033.
Elet Pharma operates in the chemicals industry, in the manufacturing segment.